Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
Mirjam B. Zeisel(University Hospital of Zurich), Fabien Zoulim(Hôpital de la Croix-Rousse), Michael Kann(Sahlgrenska University Hospital), Monsef Benkirane(Centre National de la Recherche Scientifique), Christian Trépo(Université Claude Bernard Lyon 1), Brigitte Autran(Sorbonne Université), Camille Sureau(Génomes, biologie cellulaire et thérapeutiques), Jia‐Horng Kao(National Taiwan University Hospital), Massimo Levrero(Northwest Medical Specialties), Karine Lacombe(Inserm), David Durantel(Université Claude Bernard Lyon 1), Percy A. Knolle(TUM Klinikum), Jürgen Beck(University Medical Center Freiburg), Hélène Strick‐Marchand(Institut Pasteur), Raymond F. Schinazi(Children's Healthcare of Atlanta), Julie Lucifora(Université Claude Bernard Lyon 1), Fabrice Carrat(Inserm), Françoise Barré‐Sinoussi(Institut Pasteur), Jean-François Delfraissy(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), William S. Mason(Fox Chase Cancer Center), Marie-Louise Michel(Institut Pasteur), François‐Loïc Cosset(Université Claude Bernard Lyon 1)
Cited by 273
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
|Gastroenterology|2009|693